Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17404093rdf:typepubmed:Citationlld:pubmed
pubmed-article:17404093lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:17404093lifeskim:mentionsumls-concept:C0280100lld:lifeskim
pubmed-article:17404093lifeskim:mentionsumls-concept:C1999216lld:lifeskim
pubmed-article:17404093lifeskim:mentionsumls-concept:C0205390lld:lifeskim
pubmed-article:17404093lifeskim:mentionsumls-concept:C0201734lld:lifeskim
pubmed-article:17404093lifeskim:mentionsumls-concept:C1709518lld:lifeskim
pubmed-article:17404093lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:17404093lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:17404093lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:17404093lifeskim:mentionsumls-concept:C1956394lld:lifeskim
pubmed-article:17404093pubmed:issue7lld:pubmed
pubmed-article:17404093pubmed:dateCreated2007-4-3lld:pubmed
pubmed-article:17404093pubmed:abstractTextThioredoxin-1 (Trx-1) is a cellular redox protein that promotes tumor growth, inhibits apoptosis, and up-regulates hypoxia-inducible factor-1alpha and vascular endothelial growth factor. Objectives of this study were to determine safety, tolerability, pharmacodynamics, and pharmacokinetics of PX-12, a small-molecule inhibitor of Trx-1.lld:pubmed
pubmed-article:17404093pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17404093pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17404093pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17404093pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17404093pubmed:languageenglld:pubmed
pubmed-article:17404093pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17404093pubmed:citationSubsetIMlld:pubmed
pubmed-article:17404093pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17404093pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17404093pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17404093pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17404093pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17404093pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17404093pubmed:statusMEDLINElld:pubmed
pubmed-article:17404093pubmed:monthAprlld:pubmed
pubmed-article:17404093pubmed:issn1078-0432lld:pubmed
pubmed-article:17404093pubmed:authorpubmed-author:RamanathanRam...lld:pubmed
pubmed-article:17404093pubmed:authorpubmed-author:BelaniChandra...lld:pubmed
pubmed-article:17404093pubmed:authorpubmed-author:StrattonSteve...lld:pubmed
pubmed-article:17404093pubmed:authorpubmed-author:BakerAmandaAlld:pubmed
pubmed-article:17404093pubmed:authorpubmed-author:KirkpatrickD...lld:pubmed
pubmed-article:17404093pubmed:authorpubmed-author:GreenSylvan...lld:pubmed
pubmed-article:17404093pubmed:authorpubmed-author:ChowH-H...lld:pubmed
pubmed-article:17404093pubmed:authorpubmed-author:DragovichTomi...lld:pubmed
pubmed-article:17404093pubmed:authorpubmed-author:FriedlandDavi...lld:pubmed
pubmed-article:17404093pubmed:authorpubmed-author:CordovaCather...lld:pubmed
pubmed-article:17404093pubmed:authorpubmed-author:SharlowElizab...lld:pubmed
pubmed-article:17404093pubmed:issnTypePrintlld:pubmed
pubmed-article:17404093pubmed:day1lld:pubmed
pubmed-article:17404093pubmed:volume13lld:pubmed
pubmed-article:17404093pubmed:ownerNLMlld:pubmed
pubmed-article:17404093pubmed:authorsCompleteYlld:pubmed
pubmed-article:17404093pubmed:pagination2109-14lld:pubmed
pubmed-article:17404093pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:17404093pubmed:meshHeadingpubmed-meshheading:17404093...lld:pubmed
pubmed-article:17404093pubmed:meshHeadingpubmed-meshheading:17404093...lld:pubmed
pubmed-article:17404093pubmed:meshHeadingpubmed-meshheading:17404093...lld:pubmed
pubmed-article:17404093pubmed:meshHeadingpubmed-meshheading:17404093...lld:pubmed
pubmed-article:17404093pubmed:meshHeadingpubmed-meshheading:17404093...lld:pubmed
pubmed-article:17404093pubmed:meshHeadingpubmed-meshheading:17404093...lld:pubmed
pubmed-article:17404093pubmed:meshHeadingpubmed-meshheading:17404093...lld:pubmed
pubmed-article:17404093pubmed:meshHeadingpubmed-meshheading:17404093...lld:pubmed
pubmed-article:17404093pubmed:meshHeadingpubmed-meshheading:17404093...lld:pubmed
pubmed-article:17404093pubmed:meshHeadingpubmed-meshheading:17404093...lld:pubmed
pubmed-article:17404093pubmed:meshHeadingpubmed-meshheading:17404093...lld:pubmed
pubmed-article:17404093pubmed:meshHeadingpubmed-meshheading:17404093...lld:pubmed
pubmed-article:17404093pubmed:meshHeadingpubmed-meshheading:17404093...lld:pubmed
pubmed-article:17404093pubmed:meshHeadingpubmed-meshheading:17404093...lld:pubmed
pubmed-article:17404093pubmed:meshHeadingpubmed-meshheading:17404093...lld:pubmed
pubmed-article:17404093pubmed:year2007lld:pubmed
pubmed-article:17404093pubmed:articleTitleA Phase I pharmacokinetic and pharmacodynamic study of PX-12, a novel inhibitor of thioredoxin-1, in patients with advanced solid tumors.lld:pubmed
pubmed-article:17404093pubmed:affiliationDivision of Hematology/Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.lld:pubmed
pubmed-article:17404093pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17404093pubmed:publicationTypeClinical Trial, Phase Illd:pubmed
pubmed-article:17404093pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17404093lld:pubmed